The TLR2/TLR6 ligand FSL-1 mitigates radiation-induced hematopoietic injury in mice and nonhuman primates
W. June Brickey(University of North Carolina at Chapel Hill), Jenny P.-Y. Ting, Janet A. Tooze(Wake Forest University), David L. Caudell(Wake Forest University), Shuangshuang Yang(Indiana University School of Medicine), Andrew N. Macintyre(Duke University), Kouros Owzar(Duke University), Nelson J. Chao(Duke University), Allison N. Schorzman(University of North Carolina at Chapel Hill), John D. Olson(Wake Forest University), J. Mark Cline(Wake Forest University), L.M. O’Donnell(Wake Forest University), J. Daniel Bourland(Wake Forest University), William C. Zamboni(AstraZeneca (United Kingdom)), Gregory D. Sempowski(Duke University), Zhiguo Li(Duke University), Sirui Li(New York University), Yanwan Dai(Tsinghua University), Matthew N. French(Duke University), Guannan Huang(University of North Carolina at Chapel Hill), Gregory O. Dugan(Wake Forest University), Hao Guo(University of North Carolina at Chapel Hill)
Cited by 15
Related Papers
Fatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling
|Nature Immunology|2011|1.8k
Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology
|Cancer Research|2013|1.5k
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial
|The Lancet|2009|1.4k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k
Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2020|739